Developmental changes of FOXP3-expressing CD4+CD25+ regulatory T cells and their impairment in patients with FOXP3 gene mutations

被引:53
作者
Fuchizawa, Tatsuya
Adachi, Yuichi
Ito, Yasunori
Higashiyarna, Hiroyuki
Kanegane, Hirokazu
Futatani, Takeshi
Kobayashi, Ichiro
Kamachi, Yoshiro
Sakamoto, Tatsuo
Tsuge, Ikuya
Tanaka, Hiroshi
Banham, Alison H.
Ochs, Hans D.
Miyawaki, Toshio
机构
[1] Toyama Univ, Grad Sch Med, Dept Pediat, Sugitani, Toyama 9300194, Japan
[2] Kitami Res Cross Gen Hosp, Pediat Clin, Kitami, Hokkaido, Japan
[3] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi, Japan
[4] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 47011, Japan
[5] Hirosaki Univ, Sch Med, Dept Pediat, Hirosaki, Aomori 036, Japan
[6] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England
[7] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA
关键词
FOXP3; regulatory T cells; developmental change; naive T cells; memory T cells; IPEX;
D O I
10.1016/j.clim.2007.08.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
FOXP3 is required for the generation and function of CD4(+)CD25(+) regulatory T (Treg) cells. To elucidate the biological role of Treg cells, we used a monoclonal anti-FOXP3 antibody to examine the frequencies of Treg cells, during child development. The percentages of CD4(+)CD25(+)FOXP3(+) T cells were constant shortly from after birth through adulthood. CD4(+)CD25(+)FOXP3(+) T cells in cord blood showed the naive CD45RA(+)CD45RO(-) phenotype, whereas adult CD4(+)CD25(+)FOXP3(+) T cells expressed mostly the memory CD45RA(-)CD45RO(+) phenotype. The age-dependent dominance of memory CD4(+)CD25(+)FOXP3 T cells implies functional differences between naive and memory Treg cells. Notably, four patients with FOXP3 gene mutations revealed a paucity of CD4(+)CD25(+)FOXP3(+) T cells. Importantly, one patient with a frame shift mutation, who showed typical symptoms of IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked), exhibited marked T cell activation, whereas others with missense mutations, who were clinically milder, did not. This observation suggests a possible genotype-phenotype correlation in IPEX. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:237 / 246
页数:10
相关论文
共 37 条
[1]   T regulatory cells in allergy: Novel concepts in the pathogenesis, prevention, and treatment of allergic diseases [J].
Akdis, M ;
Blaser, K ;
Akdis, CA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (05) :961-968
[2]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[3]   Prospective immunological profiling in a case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) [J].
Bakke, AC ;
Purtzer, MZ ;
Wildin, RS .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 137 (02) :373-378
[4]   FOXP3+ regulatory T cells:: Current controversies and future perspectives [J].
Banham, Alison H. ;
Powrie, Fiona M. ;
Suri-Payer, Elisabeth .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (11) :2832-2836
[5]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[6]   The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 [J].
Bennett, CL ;
Christie, J ;
Ramsdell, F ;
Brunkow, ME ;
Ferguson, PJ ;
Whitesell, L ;
Kelly, TE ;
Saulsbury, FT ;
Chance, PF ;
Ochs, HD .
NATURE GENETICS, 2001, 27 (01) :20-21
[7]  
BLAIR PJ, 1994, J IMMUNOL, V153, P3764
[8]   Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse [J].
Brunkow, ME ;
Jeffery, EW ;
Hjerrild, KA ;
Paeper, B ;
Clark, LB ;
Yasayko, SA ;
Wilkinson, JE ;
Galas, D ;
Ziegler, SF ;
Ramsdell, F .
NATURE GENETICS, 2001, 27 (01) :68-73
[9]   JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome [J].
Chatila, TA ;
Blaeser, F ;
Ho, N ;
Lederman, HM ;
Voulgaropoulos, C ;
Helms, C ;
Bowcock, AM .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (12) :R75-R81
[10]  
Clark LB, 1999, J IMMUNOL, V162, P2546